FIELD: biotechnologies.
SUBSTANCE: invention relates to compositions containing vasoactive intestinal peptide (VIP) or its fragments, and to application of such compositions in treatment of aorta fibrosis.
EFFECT: group of inventions is effective in treatment and prophylaxis of aorta fibrosis.
10 cl, 4 dwg, 2 ex
Authors
Dates
2014-12-20—Published
2010-04-06—Filed